Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Neurol.

Sec. Pediatric Neurology

Volume 16 - 2025 | doi: 10.3389/fneur.2025.1638549

This article is part of the Research TopicNew Insights into Pediatric Neurology: Neurological Disorders and Epileptic EncephalopathiesView all 12 articles

The relationship between genotype and phenotype in Chinese children with glucose transporter type 1 deficiency syndrome

Provisionally accepted
  • 1Department of Pediatrics, First Hospital, Peking University, Beijing, China
  • 2Department of Pediatrics, Peking University People’s Hospital, Beijing, China, beijing, China
  • 3Department of Pediatric Neurology, Guangdong Women and Children Hospital, Guangdong,, Guangdong, China
  • 4Department of Neurology, Beijing Children′s Hospital, Capital Medical University, Beijing, China, beijing, China

The final, formatted version of the article will be published soon.

ABSTRACT RunningTitleBackgroundGlucosetransporter type 1 deficiency syndrome (Glut1DS) is a treatable neurogeneticmetabolicdisordercausedbypathogenic variants in the SLC2A1 gene. The relationship between genotypeandphenotypehasnotbeenextensivelystudiedin large cohorts within China. This study aimed to analyze the clinical and genetic characteristics and the genotype-phenotype correlation in Chinese children with Glut1DS.MethodsClinicaldataofGlut1DSpatients, including age ofonset,clinicalmanifestations, cerebrospinal fluid (CSF) analysis,andSLC2A1 gene variants, were collected and analyzed. ResultsAtotal of 93 patients with Glut1DS were included,amongwhom65 (70%) were classical phenotypes (including55early-onset classical cases and 10 late-onset classical cases),and28 (30%)werenon-classicalphenotypes. Significant differenceswereobservedamongearly-onsetclassical,late-onset classical, and non-classical groups in terms of age of onset (p < 0.001),episodicpsychiatric/behavioral abnormalities (p = 0.012),CSF glucose levels (p < 0.001), the CSFglucosetobloodglucose (p = 0.003).Geneticvariantanalysisidentified 40 previously reported and 32 novel SLC2A1 variants.Thesevariant wereclassifiedintothree types: Type A (missense and in-frame indel variants, n = 52), Type B (frameshift, nonsense, splicing site, and initiation codon variants, n = 32), and Type C (single/multiple exon or whole-gene deletions, n = 9). No statistically significant difference Running Title was found in the distribution of these three genotypes across early-onset classical, late-onset classical, and non-classical phenotype. However, there were differences in age of onset among the three genetic variant groups (p = 0.009), with Type A variants showing a later age of onset compared to Type B variants (p = 0.014). No significant differences were observed among the three variant groups regarding CSF glucose levels, the ratio of CSF glucose to blood glucose, or CSF lactate levels. Furthermore, patients with identical variants exhibited phenotypic variability, for example, among eight patients (9%) harboring the c.997C>T (p.Arg333Trp) variant, six had early-onset classical phenotypes, while two had non-classical phenotypes. Conclusion Glut1DS predominantly manifests as the classical phenotype, with the early-onset classical phenotype presenting at the youngest age and exhibiting the most severe clinical symptoms. Patients with this type also showed lower CSF glucose levels and a lower CSF glucose to blood glucose ratio compared to other types. Missense and in-frame indel variants were associated with a later age of onset compared to other types of genetic variants. No significant correlations were found between genotype and clinical classification or CSF glucose levels.

Keywords: glucose transporter type 1 deficiency syndrome, SLC2A1, genotype-phenotype correlation, Seizures, Movement Disorders

Received: 30 May 2025; Accepted: 02 Sep 2025.

Copyright: © 2025 Zhang, Zhang, Zhang, Wen, Jiaping, Xiong, Jiang and Bao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Xinhua Bao, Department of Pediatrics, First Hospital, Peking University, Beijing, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.